124 related articles for article (PubMed ID: 33609081)
1. Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes.
Yan X; Wang L; Jiang L; Luo Y; Lin P; Yang W; Ren Y; Ma L; Zhou X; Mei C; Ye L; Xu G; Xu W; Yang H; Lu C; Jin J; Tong H
Cancer Med; 2021 Mar; 10(5):1759-1771. PubMed ID: 33609081
[TBL] [Abstract][Full Text] [Related]
2. Multiplex ligation-dependent probe amplification assay identifies additional copy number changes compared with R-band karyotype and provide more accuracy prognostic information in myelodysplastic syndromes.
Wang J; Ai X; Qin T; Xu Z; Zhang Y; Liu J; Li B; Fang L; Zhang H; Pan L; Hu N; Qu S; Cai W; Ru K; Jia Y; Huang G; Xiao Z
Oncotarget; 2017 Jan; 8(1):1603-1612. PubMed ID: 27906673
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of
Lin ME; Hou HA; Tsai CH; Wu SJ; Kuo YY; Tseng MH; Liu MC; Liu CW; Chou WC; Chen CY; Tang JL; Yao M; Li CC; Huang SY; Ko BS; Hsu SC; Lin CT; Tien HF
Clin Epigenetics; 2018; 10():42. PubMed ID: 29619119
[TBL] [Abstract][Full Text] [Related]
4. The clinical characteristics, gene mutations and outcomes of myelodysplastic syndromes with diabetes mellitus.
Xu F; Jin J; Guo J; Xu F; Chen J; Liu Q; Song L; Zhang Z; Zhou L; Su J; Xiao C; Zhang Y; Yan M; He Q; Wu D; Chang C; Li X; Wu L
J Cancer Res Clin Oncol; 2024 Feb; 150(2):71. PubMed ID: 38305890
[TBL] [Abstract][Full Text] [Related]
5. Complex karyotype determined using conventional cytogenetic analysis is a poor prognostic factor in patients with multiple myeloma.
Uryu H; Mishima Y; Ishihara Y; Shirouchi Y; Yamauchi N; Hirano M; Hirano K; Teramoto Y; Yoshida K; Maruyama D
J Clin Exp Hematop; 2024; 64(1):10-20. PubMed ID: 38538316
[TBL] [Abstract][Full Text] [Related]
6. Multiplex ligation-dependent probe amplification identifies copy number changes in normal and undetectable karyotype MDS patients.
Ma J; Ai X; Wang J; Xing L; Tian C; Yang H; Yu Y; Zhao H; Wang X; Zhao Z; Wang Y; Cao Z
Ann Hematol; 2021 Sep; 100(9):2207-2214. PubMed ID: 33990890
[TBL] [Abstract][Full Text] [Related]
7. Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome.
Sloand EM; Mainwaring L; Fuhrer M; Ramkissoon S; Risitano AM; Keyvanafar K; Lu J; Basu A; Barrett AJ; Young NS
Blood; 2005 Aug; 106(3):841-51. PubMed ID: 15827127
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic and Molecular Associations with Outcomes in Higher-Risk Myelodysplastic Syndromes Treated with Hypomethylating Agents plus Venetoclax.
Bazinet A; Desikan SP; Li Z; Rodriguez-Sevilla JJ; Venugopal S; Urrutia S; Montalban-Bravo G; Sasaki K; Chien KS; Hammond D; Kanagal-Shamanna R; Ganan-Gomez I; Kadia TM; Borthakur G; DiNardo CD; Daver NG; Jabbour EJ; Ravandi F; Kantarjian H; Garcia-Manero G
Clin Cancer Res; 2024 Apr; 30(7):1319-1326. PubMed ID: 38300723
[TBL] [Abstract][Full Text] [Related]
9. Complex Karyotype in Hematological Diseases: A 6-Year Single Centre Study from Pakistan.
Waheed S; Hassan J; Naz M; Maqsood S; Abid M; Shan S; Nadeem M; Shamsi TS
J Oncol; 2018; 2018():2019239. PubMed ID: 29971104
[TBL] [Abstract][Full Text] [Related]
10. Impact of copy neutral loss of heterozygosity and total genome aberrations on survival in myelodysplastic syndrome.
Yeung CCS; McElhone S; Chen XY; Ng D; Storer BE; Deeg HJ; Fang M
Mod Pathol; 2018 Apr; 31(4):569-580. PubMed ID: 29243741
[TBL] [Abstract][Full Text] [Related]
11. Ectopic expression of the transcription factor ONECUT3 drives a complex karyotype in myelodysplastic syndromes.
Luo Y; Feng X; Lang W; Xu W; Wang W; Mei C; Ye L; Zhu S; Wang L; Zhou X; Zeng H; Ma L; Ren Y; Jin J; Xu R; Huang G; Tong H
J Clin Invest; 2024 Feb; 134(8):. PubMed ID: 38386414
[TBL] [Abstract][Full Text] [Related]
12. Co-occurrence of High-Risk Myelodysplastic Syndrome With a Complex Karyotype/TP53 Mutation and IgG Lambda Monoclonal Gammopathy of Undetermined Significance.
Mir M; Aiman W; Baah E; Guron G; Shaaban H
Cureus; 2024 Apr; 16(4):e58451. PubMed ID: 38765410
[TBL] [Abstract][Full Text] [Related]
13. Genetics and Epigenetics of Myelodysplastic Syndromes and Response to Drug Therapy: New Insights.
Shahrabi S; Khosravi A; Shahjahani M; Rahim F; Saki N
Oncol Rev; 2016 Oct; 10(2):311. PubMed ID: 28058097
[TBL] [Abstract][Full Text] [Related]
14. Faggot cells observed in a patient with myelodysplastic syndrome with increased blasts.
Ito M; Fukushima N
Int J Hematol; 2024 May; 119(5):476-478. PubMed ID: 38554197
[No Abstract] [Full Text] [Related]
15. Ring Chromosomes in Hematological Malignancies Are Associated with
Boyd RJ; Murry JB; Morsberger LA; Klausner M; Chen S; Gocke CD; McCallion AS; Zou YS
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001699
[TBL] [Abstract][Full Text] [Related]
16. Disease-controlled multiple myeloma in a patient with 17p gain and t(4;14): A case report.
Tang X; Xu R; Zheng W; Zhou Y; Cui S; Wang Y
Heliyon; 2024 Apr; 10(7):e28950. PubMed ID: 38596106
[TBL] [Abstract][Full Text] [Related]
17. Hemivertebra with pathogenic microdeletion of chromosome 9.
Dorjey Y; Gyeltshen T
Clin Case Rep; 2024 Apr; 12(4):e8750. PubMed ID: 38590330
[TBL] [Abstract][Full Text] [Related]
18. Healthy Lifestyle and Clonal Hematopoiesis of Indeterminate Potential: Results From the Women's Health Initiative.
Haring B; Reiner AP; Liu J; Tobias DK; Whitsel E; Berger JS; Desai P; Wassertheil-Smoller S; LaMonte MJ; Hayden KM; Bick AG; Natarajan P; Weinstock JS; Nguyen PK; Stefanick M; Simon MS; Eaton CB; Kooperberg C; Manson JE
J Am Heart Assoc; 2021 Feb; 10(5):e018789. PubMed ID: 33619969
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1-mutated acute myeloid leukaemia.
Loghavi S; DiNardo CD; Furudate K; Takahashi K; Tanaka T; Short NJ; Kadia T; Konopleva M; Kanagal-Shamanna R; Farnoud NR; Pierce S; Khoury JD; Jorgensen JL; Patel KP; Daver N; Yilmaz M; Medeiros LJ; Kantarjian H; Ravandi F; Wang SA
Br J Haematol; 2021 Mar; 192(6):1054-1063. PubMed ID: 33618432
[TBL] [Abstract][Full Text] [Related]
20. Herboxidiene Features That Mediate Conformation-Dependent SF3B1 Interactions to Inhibit Splicing.
Gamboa Lopez A; Allu SR; Mendez P; Chandrashekar Reddy G; Maul-Newby HM; Ghosh AK; Jurica MS
ACS Chem Biol; 2021 Mar; 16(3):520-528. PubMed ID: 33617218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
